Gi nutritional pharm

52
1 GI DRUGS & NUTRITIONAL DRUGS By Deidre N. Pickett R.N., MSN HOLMES COMMUNITY COLLEGE SCHOOL OF NURSING Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Transcript of Gi nutritional pharm

Page 1: Gi nutritional pharm

1

GI DRUGS & NUTRITIONAL DRUGS

By

Deidre N. Pickett

R.N., MSN

HOLMES COMMUNITY COLLEGE SCHOOL OF NURSING

Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Page 2: Gi nutritional pharm

2

Drugs for Peptic Ulcer Disease (PUD)

Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Page 3: Gi nutritional pharm

3Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Pathogenesis of Peptic Ulcers

• Defensive factors– Mucus– Bicarbonate– Blood flow– Prostaglandins

• Aggressive factors– Helicobacter pylori – NSAIDs– Gastric acid– Pepsin – Smoking

Page 4: Gi nutritional pharm

4Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Figure 76-1 The relationship of mucosal defenses and aggressive factors to health and peptic ulcer disease.

Page 5: Gi nutritional pharm

5Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Figure 76-2 A model of the regulation of gastric acid secretion showing the actions of antisecretory drugs and antacids.

Page 6: Gi nutritional pharm

6Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Helicobacter pylori

• Test: breath test or serum

• Treatment (two antibiotics are prescribed)

– Bismuth compounds

– Clarithromycin

– Amoxicillin

– Tetracycline

– Metronidazole

Page 7: Gi nutritional pharm

7

List of Available NSAIDs:List of Available NSAIDs:Prescription & OTC Prescription & OTC **

NON-SALICYLATESNON-SALICYLATES SALICYLATES COX-2 INHIBITORS SALICYLATES COX-2 INHIBITORS Diclofenac (Voltaren)Diclofenac (Voltaren) Aspirin Aspirin a,ca,c (Zorprin, Easprin) (Zorprin, Easprin) Celecoxib Celecoxib (Celebrex)(Celebrex)Diclofenac/Misoprostol (Arthrotec)Diclofenac/Misoprostol (Arthrotec) Diflunisal (Dolobid)Diflunisal (Dolobid) Rofecoxib Rofecoxib (Vioxx)(Vioxx)Etodolac (Lodine)Etodolac (Lodine) Salsalate (Disalcid, Salflex)Salsalate (Disalcid, Salflex) Valdecoxib Valdecoxib (Bextra)(Bextra)Fenoprofen (Nalfon)Fenoprofen (Nalfon) Choline salicylate (Trilisate)Choline salicylate (Trilisate)Flurbiprofen (Ansaid)Flurbiprofen (Ansaid) Magnesium salicylate (Magan)Magnesium salicylate (Magan) Ibuprofen Ibuprofen a,b,c a,b,c (Motrin, Advil) (Motrin, Advil) Indomethacin (Indocin)Indomethacin (Indocin)Ketoprofen Ketoprofen a,b,ca,b,c(Orudis) (Orudis)

Ketorolac (Toradol)Ketorolac (Toradol)cc

MeclofenamateMeclofenamateMefenamic acid (Ponstel)Mefenamic acid (Ponstel)Meloxicam (Mobic)Meloxicam (Mobic)Nabumetone (Relafen)Nabumetone (Relafen)Naproxen Naproxen a,b,ca,b,c(Naprosyn, Anaprox)(Naprosyn, Anaprox)Oxaprozin (Daypro)Oxaprozin (Daypro)Piroxicam (Feldene)Piroxicam (Feldene)Sulindac (Clinoril)Sulindac (Clinoril)Tolmetin (Tolectin)Tolmetin (Tolectin)

aa Also available as OTC preparations in U.S. Also available as OTC preparations in U.S.b b OTC dose is usually half of prescribed doseOTC dose is usually half of prescribed doseC C All OTC NSAIDs are All OTC NSAIDs are non-selectivenon-selective COX COX InhibitorsInhibitors

* * List of trade names is not List of trade names is not exhaustiveexhaustive

Comments on Over-the-Counter Comments on Over-the-Counter Preparations:Preparations:

Page 8: Gi nutritional pharm

8

Endoscopic PhotographEndoscopic Photographof Gastric Ulcerof Gastric Ulcer

Page 9: Gi nutritional pharm

9

Peptic Ulcer Disease

Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Page 10: Gi nutritional pharm

10Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Drugs for Peptic Ulcer Disease

• Peptic ulcer disease

– Upper GI disorders

– Degrees of erosion of the gut wall

• Cause

– Imbalance between mucosal and aggressive factors

Page 11: Gi nutritional pharm

11Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Classes of Antiulcer Drugs

• Antibiotics

• Antisecretory agents

• Mucosal protectants

• Antisecretory agents that enhance mucosal defenses

• Antacids

Page 12: Gi nutritional pharm

12Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Histamine2-Receptor Antagonists

• Cimetidine [Tagamet]

• Ranitidine [Zantac]

• Ranitidine bismuth citrate [Tritec]

• Famotidine [Pepcid]

• Nizatidine [Axid]

Page 13: Gi nutritional pharm

13Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Proton Pump Inhibitors

• Omeprazole [Prilosec]

– Inhibits gastric secretion

– Short half-life

– Used for short-term therapy

• Adverse effects

– Headache

– Gastrointestinal

Page 14: Gi nutritional pharm

14Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Sucralfate [Carafate]

• Protective barrier up to 6 hours

• Uses

– Acute ulcers

• Adverse effects

– Constipation

• Drug interactions

Page 15: Gi nutritional pharm

15

CYTOTEC

Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Page 16: Gi nutritional pharm

16

Laxatives

Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Page 17: Gi nutritional pharm

17Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Laxatives

• Used to ease or stimulate defecation

– Soften the stool

– Increase stool volume

– Hasten fecal passage through the intestine

– Facilitate evacuation from the rectum

Page 18: Gi nutritional pharm

18Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Indications for Laxative Use

• Constipation is determined by stool consistency and frequency of defecation

• Indications

– Diagnosis

– Treatment/procedure preparation

– Constipation

– Poisoning

Page 19: Gi nutritional pharm

19Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Classification of Laxatives

• Bulk-forming laxatives

– Psyllium [Metamucil]

• Surfactant laxatives

– Docusate sodium [Colace]

• Stimulant laxatives

– Bisacodyl [Dulcolax]

• Osmotic laxatives

– Milk of magnesia (MOM)

Page 20: Gi nutritional pharm

20

Other Gastrointestinal Drugs

Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Page 21: Gi nutritional pharm

21

ANTIACIDS

Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Page 22: Gi nutritional pharm

22Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Antiemetics

• Ondansetron [Zofran]

– Blocks type 3 serotonin receptors on afferent vagal nerve

– More effective when used with dexamethasone

Page 23: Gi nutritional pharm

23Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Figure 78-1 The emetic response: stimuli, pathways, and receptors. CTZ = chemoreceptor trigger zone.

Page 24: Gi nutritional pharm

24Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Drugs for Motion Sickness

• Scopolamine• Side effects

– Dry mouth– Blurred vision– Drowsiness

• Antihistamines

Page 25: Gi nutritional pharm

25Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Antidiarrheal Agents

• Opioids

– Diphenoxylate [Lomotil]

– Activate opioid receptors in the GI tract, decrease intestinal motility, slow intestinal transmit, more time for fluids and electrolytes to be absorbed

Page 26: Gi nutritional pharm

26Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Drugs for Inflammatory Bowel Disease (IBD)

• Tricyclic antidepressants

• Antibiotics

• Acid suppressants

• Alosetron [Lotronex]

• Tegaserod [Zelnorm]

Page 27: Gi nutritional pharm

27Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

More Drugs for IBD

• Aminosalicylates

• Glucocorticoids

• Immunomodulators

Page 28: Gi nutritional pharm

28Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Vitamins

Page 29: Gi nutritional pharm

29Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Intake of Vitamins

• Recommended Dietary Allowances (RDAs) for vitamins are set by the Food and Nutrition Board of the Nation Academy of Sciences and represent the average daily dietary intake sufficient to meet the nutrient requirements of nearly all (97%-98%) healthy individuals in a particular life stage or gender.

Page 30: Gi nutritional pharm

30Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Intake of Vitamins (cont’d)• The Tolerable Upper Intake Limit (UL) for a

vitamin is the highest average daily intake that can be consumed by nearly everyone without a significant risk of adverse effects.

• The UL is an index of safety—not a recommendation to exceed the RDA.

Page 31: Gi nutritional pharm

31Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Vitamins

• Classification of vitamins

• Fat soluble

– Vitamins A, D, E, K

• Water soluble

– Vitamin C

– Vitamin B complex—thiamin, riboflavin, niacin, pyridoxine, panthothenic acid, biotin, folic acid, cyanocobalamin

Page 32: Gi nutritional pharm

32Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Vitamin A (Retinol)

• Deficiency causes

– Night blindness

– Xerophthalmia

– Keratomalacia

– Blindness

– Therapeutic uses

Page 33: Gi nutritional pharm

33Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Vitamins D and E

• Vitamin D

– Regulates calcium and phosphorus

– Deficiency causes rickets or osteomalacia

• Vitamin E

– Antioxidant properties

– Dietary sources—fresh greens, seeds, oils

Page 34: Gi nutritional pharm

34Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Vitamin K

• Action required for synthesis of prothrombin and other clotting factors

• Deficiency produces bleeding• Adverse effects

– Hypersensitivity reaction– Hyperbilirubinemia

• Therapeutic use– Warfarin overdose

Page 35: Gi nutritional pharm

35Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Vitamin C

• Action required for production of collagen and other compounds that bind cells together.

• Has antioxidant properties

• Facilitates iron absorption

• Deficiency can lead to scurvy

Page 36: Gi nutritional pharm

36Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Vitamin B Complex

• Niacin (nicotinic acid)

• Riboflavin (vitamin B2)

• Thiamin (vitamin B1)

• Pyridoxine (vitamin B6)

• Cyanocobalamin (vitamin B12)

• Folic acid

Page 37: Gi nutritional pharm

37Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Enteral and

Parenteral Nutrition

Page 38: Gi nutritional pharm

38Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Enteral and Parenteral Nutrition

• Enteral nutrition is defined as provision of nutrients by way of the GI tract

• Criteria

– Patients with a healthy digestive tract but are unable or unwilling to eat sufficient food

– Patients who have a digestive or absorptive disorder that cannot be overcome by diet modification

• Contraindications

Page 39: Gi nutritional pharm

39Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Enteral Modes of Delivery

• Tube placement– Nasogastric– Nasoduodenal– Nasojejunal– PEG tube

• Schedule of administration– Continuous– Cyclic– Intermittent– Bolus

Page 40: Gi nutritional pharm

40Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Enteral Modes of Delivery (cont’d)

• Method of administration

– Syringe

– Gravity

– Enteral pump

Page 41: Gi nutritional pharm

41Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Components of Enteral Nutrition

• Amino acids

• Carbohydrates

• Fats

• Electrolytes

• Vitamins

• Trace elements

Page 42: Gi nutritional pharm

42Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Complications of Enteral Nutrition

• Aspiration

• Pneumonitis

• Diarrhea

• Vomiting

• Insufficient gastric emptying

• GI bleeding

• Hyperglycemia

• Electrolyte imbalances

• Fatty acid deficiency

Page 43: Gi nutritional pharm

43Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Parenteral Nutritional Therapy

• Routes – Peripheral vein– Central venous catheter

• Components– Amino acids, dextrose, fats, carbohydrates,

vitamins, electrolytes, and trace elements• Complications

– Increased blood urea nitrogen (BUN)– Glucose intolerance– Hyperlipidemia– Allergy

Page 44: Gi nutritional pharm

44Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Complications of Parenteral Therapy

• Infection

• Metabolic disturbances

• Catheter-related complications

• Pneumothorax

• Venous thrombosis

Page 45: Gi nutritional pharm

45Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Complications of Parenteral Therapy

• Infection

• Metabolic disturbances

• Catheter-related complications

• Pneumothorax

• Venous thrombosis

Page 46: Gi nutritional pharm

46Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Drugs for Obesity

Page 47: Gi nutritional pharm

47Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Drugs for Obesity

• Assessment—obesity

– Degree of obesity

• Body mass index (BMI)

– Pattern of fat distribution

• Waist circumference

– Presence of risk factors

• Coronary heart disease, diabetes, hypertension

• Other atherosclerotic diseases, sleep apnea

Page 48: Gi nutritional pharm

48Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Figure 81-1 Weight classification based on body mass index (BMI).

Page 49: Gi nutritional pharm

49Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Weight Loss Therapy Guidelines

• Who should be treated?

– BMI of 30 or more

– BMI of 25 to 25.9 with two risk factors

– Waist circumference with two risk factors

Page 50: Gi nutritional pharm

50Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Treatment Modalities

• Diet therapy

• Exercise

• Behavior modification

• Drug therapy

• Bariatric therapy

Page 51: Gi nutritional pharm

51Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Sibutramine [Meridia]• Suppresses appetite and decreases

absorption of fat• Drug interactions• Adverse effects

– Headache

– Dry mouth– Constipation

– Elevated heart rate– Insomnia

– Elevated blood pressure

– Nervousness

– Anxiety

Page 52: Gi nutritional pharm

52Elsevier Inc. items and derived items © 2007 by Saunders, an imprint of Elsevier Inc.

Orlistat [Xenical]

• Acts in the GI tract to reduce absorption of fat

• Adverse effects

– GI effects

– Reduced absorption of fat-soluble vitamins

• Caution

– Warfarin

– Wardrobe Malfunctions are highly likely.